Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick M Lynch

Showing results (81-90 of 135) with videos related to

Pageof 14
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 9, 2004
Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patientsFrank A Sinicrope, Elizabeth Half, Jeffrey S Morris, et al.
Surgical Endoscopy|September 10, 2020
Efficacy of uncovered colonic stents for extrinsic versus intrinsic malignant large bowel obstructionBrian R Weston, Jigar M Patel, Mala Pande, et al.
Human Mutation|January 7, 2010
Microsatellite instability in the peripheral blood leukocytes of HNPCC patientsMary I Coolbaugh-Murphy, Jing-Ping Xu, Louis S Ramagli, et al.
Familial Cancer|March 28, 2016
Identification of a novel PMS2 alteration c.505C>G (R169G) in trans with a PMS2 pathogenic mutation in a patient with constitutional mismatch repair deficiencyMaureen E Mork, Ester Borras, Melissa W Taggart, et al.
Familial Cancer|June 21, 2012
Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registryMala Pande, Chongjuan Wei, Jinyun Chen, et al.
Oncotarget|June 25, 2019
Functional characterization of <i>CNOT3</i> variants identified in familial adenomatous polyposis adenomasRichard Glenn C Delacruz, Imelda T Sandoval, Kyle Chang, et al.
Cancer Research|April 17, 2004
Serum proteomic profiles suggest celecoxib-modulated targets and response predictorsZhen Xiao, Brian T Luke, Grant Izmirlian, et al.
Cancer|September 1, 2005
Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagusPooja R Rohatgi, Stephen G Swisher, Arlene M Correa, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 3, 2017
<i>In Silico</i> Systems Biology Analysis of Variants of Uncertain Significance in Lynch Syndrome Supports the Prioritization of Functional Molecular ValidationEster Borras, Kyle Chang, Mala Pande, et al.
Cancer Medicine|February 18, 2017
A comparison between Lynch syndrome and sporadic colorectal cancer survivors' satisfaction with their healthcare providersAllison M Burton-Chase, Wendy M Parker, Katrina M Polivka, et al.
Pageof 14

Showing results (81-90 of 135) with videos related to

Sort By:
Pageof 14
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 9, 2004
Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patientsFrank A Sinicrope, Elizabeth Half, Jeffrey S Morris, et al.
Surgical Endoscopy|September 10, 2020
Efficacy of uncovered colonic stents for extrinsic versus intrinsic malignant large bowel obstructionBrian R Weston, Jigar M Patel, Mala Pande, et al.
Human Mutation|January 7, 2010
Microsatellite instability in the peripheral blood leukocytes of HNPCC patientsMary I Coolbaugh-Murphy, Jing-Ping Xu, Louis S Ramagli, et al.
Familial Cancer|March 28, 2016
Identification of a novel PMS2 alteration c.505C>G (R169G) in trans with a PMS2 pathogenic mutation in a patient with constitutional mismatch repair deficiencyMaureen E Mork, Ester Borras, Melissa W Taggart, et al.
Familial Cancer|June 21, 2012
Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registryMala Pande, Chongjuan Wei, Jinyun Chen, et al.
Oncotarget|June 25, 2019
Functional characterization of <i>CNOT3</i> variants identified in familial adenomatous polyposis adenomasRichard Glenn C Delacruz, Imelda T Sandoval, Kyle Chang, et al.
Cancer Research|April 17, 2004
Serum proteomic profiles suggest celecoxib-modulated targets and response predictorsZhen Xiao, Brian T Luke, Grant Izmirlian, et al.
Cancer|September 1, 2005
Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagusPooja R Rohatgi, Stephen G Swisher, Arlene M Correa, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 3, 2017
<i>In Silico</i> Systems Biology Analysis of Variants of Uncertain Significance in Lynch Syndrome Supports the Prioritization of Functional Molecular ValidationEster Borras, Kyle Chang, Mala Pande, et al.
Cancer Medicine|February 18, 2017
A comparison between Lynch syndrome and sporadic colorectal cancer survivors' satisfaction with their healthcare providersAllison M Burton-Chase, Wendy M Parker, Katrina M Polivka, et al.
Pageof 14